Thanks to MAHA, whole milk en vogue again

And with gene therapy under fire, what's next for Sarepta?

June 21, 2025 Check out STAT+

Sponsored By

STAT Why MAHA wants whole milk back on the table In the nutrition world, the question of how whole milk compares with lower-fat options is the subject of debate. In MAHA world, it's time to embrace change. By Sarah Todd NIH STAT+ | Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official Nicole Verdun's ouster followed a disagreement over review of cell therapy for Duchenne muscular dystrophy, long-simmering tensions over management style. By Adam Feuerstein, Matthew Herper, Jason Mast, and Lizzy Lawrence Kristoffer Tripplaar/Sipa via AP STAT+ | What's next for Sarepta Therapeutics with gene therapy under fire? With a tragedy in the news — the death of a second child tied to the therapy — the company faces market consequences, too. By Adam Feuerstein STAT+ | Gilead's CEO on the approval of a powerful new drug to prevent HIV The powerful shot, to be sold as Yeztugo, can prevent people from contracting HIV with just two doses a year. By Matthew Herper STAT+ | Private equity firm will finance Harvard research lab, in possible template for future Turkish private equity firm commits $39 million to support research by Gökhan Hotamışlıgil, with option to invest in future drug candidates from his lab. By Allison DeAngelis STAT+ | Vinay Prasad named chief medical and science officer at FDA Vinay Prasad is taking on top roles at the FDA, solidifying his position as a top advisor to Commissioner Marty Makary. By Lizzy Lawrence STAT+ | China, where obesity levels are low, becomes hotbed for weight loss drug trials STAT's Obesity Drug Tracker update looks at how China, a country with a low percentage of overweight people, became a hotbed of weight loss drug trials. By Allison DeAngelis Opinion: Six former CDC vaccine advisory committee chairs warn: U.S. risks losing access to life-saving immunizations We are witnessing a dismantling of the systems that develop, license, recommend, and monitor vaccines, according to vaccine experts. By Grace Lee, Nancy Bennett, Jonathan Temte, Carol Baker, Myron Levin, and José Romero

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser